StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

LeonaBio's EPS for the twelve months ending Jun 30, 2026 was -$19.72. For fiscal 2025 it was -$24.70. The highest annual figure on record is -$14.50 in fiscal 2019.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.70–
FY2024Dec 31, 2024-$25.19–
FY2023Dec 31, 2023-$30.90–
FY2022Dec 31, 2022-$25.30–
FY2021Dec 31, 2021-$14.90–
FY2020Dec 31, 2020-$16.70–
FY2019Dec 31, 2019-$14.50–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.80–
Q1 FY2026Mar 31, 2026-$1.73–
Q4 FY2025Dec 31, 2025-$15.51–
Q3 FY2025Sep 30, 2025-$1.68–
Q2 FY2025Jun 30, 2025-$1.78–
Q1 FY2025Mar 31, 2025-$2.34–
Q4 FY2024Dec 31, 2024-$3.88–
Q3 FY2024Sep 30, 2024-$7.46–
Q2 FY2024Jun 30, 2024-$7.00–
Q1 FY2024Mar 31, 2024-$6.90–
Q4 FY2023Dec 31, 2023-$7.16–
Q3 FY2023Sep 30, 2023-$8.70–
Q2 FY2023Jun 30, 2023-$7.80–
Q1 FY2023Mar 31, 2023-$7.30–
Q4 FY2022Dec 31, 2022-$7.96–
Q3 FY2022Sep 30, 2022-$5.30–
Q2 FY2022Jun 30, 2022-$6.50–
Q1 FY2022Mar 31, 2022-$5.60–
Q4 FY2021Dec 31, 2021-$4.37–
Q3 FY2021Sep 30, 2021-$4.20–
Q2 FY2021Jun 30, 2021-$3.80–
Q1 FY2021Mar 31, 2021-$2.50–
Q3 FY2020Sep 30, 2020-$11.20–
Q2 FY2020Jun 30, 2020-$4.80–
Q1 FY2020Mar 31, 2020-$4.80–
Q4 FY2019Dec 31, 2019-$2.70–
Q3 FY2019Sep 30, 2019-$4.30–

More LeonaBio figures

See a number that looks wrong?